(Medical Xpress) -- A new mouthwash developed by a microbiologist at the UCLA School of Dentistry is highly successful in targeting the harmful Streptococcus mutans bacteria that is the principal cause tooth decay and cavities.
Health Nov 16, 2011 | 4.6 / 5 (13) | 33 |
A combination of an oral drug, called sorafenib, and a method for injecting microbeads of chemotherapy directly into tumors has been proven safe for liver cancer patients and may improve outcomes for those who have these ...
Cancer Sep 30, 2011 | 5 / 5 (3) | 0 |
It's well known that exercising reduces body weight because it draws on fat stores that muscle can burn as fuel. But a new study at Sanford-Burnham Medical Research Institute (Sanford-Burnham) suggests that ...
Medical research Feb 06, 2012 | 5 / 5 (3) | 0 |
Stanford University School of Medicine scientists have created a mouse model of muscular dystrophy in which degenerating muscle tissue gives off visible light. The observed luminescence occurs only in damaged muscle tissue ...
Medical research Apr 24, 2013 | 5 / 5 (3) | 0 |
Scientists may have a way to make the powerful cancer drug cisplatin less toxic to the kidneys and more effective against some cancers.
Cancer Jun 02, 2011 | 4.7 / 5 (3) | 0 |
Investigators at the Stanford University School of Medicine have developed a novel protocol that allows kidney-transplant recipients to jettison their indispensable immune-suppressing drugs. The protocol could also spell ...
Medications Oct 05, 2011 | 4.7 / 5 (3) | 0
First study on long-term cognitive effects of breast cancer CMF chemotherapy finds subtle impairment
Dutch investigators have reported that women who received CMF chemotherapy (a combination regimen including the drugs cyclophosphamide, methotrexate, and 5-fluorouracil) for breast cancer between 1976 and 1995 scored worse ...
Cancer Feb 27, 2012 | 4.7 / 5 (3) | 0 |
Commentary: Drug companies must report clinical trial results, even when they won't lead to a product
Drug companies sponsoring human trials of possible new medications have ethical responsibilities to study participants and to science to disclose the results of their clinical research -- even when product development is ...
Medications Sep 28, 2011 | 5 / 5 (2) | 1 |
A dirty packing facility at a Colorado farm was the likely source of an outbreak of listeria in cantaloupes that killed 25 people in the US since August, health authorities said Wednesday.
Diseases, Conditions, Syndromes Oct 19, 2011 | 5 / 5 (2) | 0
Over 17,000 patients will have been diagnosed with locally-advanced pancreatic cancer in the United States in 2011. Surgery is not a treatment option for these patients whose tumor has grown beyond the pancreas to surrounding ...
Cancer Dec 14, 2011 | 5 / 5 (2) | 0
Investigators from Vanderbilt-Ingram Cancer Center (VICC) and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival.
Cancer Feb 22, 2012 | 5 / 5 (2) | 0 |
Investigators at the Stanford University School of Medicine have shown that removing a matched set of molecules that typically help to regulate the brain's capacity for forming and eliminating connections between nerve cells ...
Neuroscience Mar 21, 2012 | 5 / 5 (2) | 0 |
The University of Colorado Cancer Center, together with other participating academic medical centers, recently opened a phase I human clinical trial of the drug OMP-54F28 in patients with advanced solid tumor cancers. OMP-54F28, ...
Cancer Oct 03, 2012 | 5 / 5 (2) | 0
Researchers conducting a preclinical study in mice successfully used targeted molecular therapy to block mostly untreatable nerve tumors that develop in people with the genetic disorder Neurofibromatosis 1 (NF1).
Cancer Dec 10, 2012 | 5 / 5 (2) | 0 |
Bone marrow transplant is a key treatment for patients with leukemia, lymphoma, multiple myeloma and other blood disorders.
Medical research Mar 01, 2013 | 5 / 5 (2) | 0 |